Learn To Psoriasis Free For Life!!!
Click Here
Psoriasis New Treatments 2009
Vision therapy Shopsters autoimmune (2009 - 2014) New Market Report
Autoimmune diseases result from an overactive immune response a body of work against their own cells. The disease is classified into two categories: systemic autoimmune diseases, affecting various organs and localized autoimmune diseases affecting a single organ. Some 80 autoimmune diseases are recognized in two categories. The disease has affected over 300 million people worldwide in 2009. It no specific reasons have been discovered to date for the onset of the disease. Women are more prone to autoimmune diseases, with 70% 75% of all patients with autoimmune diseases.
The global market for the treatment of autoimmune diseases is discussed in sub-applications, products, services and technologies. The global market for the treatment of autoimmune diseases is estimated at 37.84 billion U.S. dollars in 2009 and growing at a compound annual rate 12.7% from 2009 to 2014 to reach an estimated $ 68.81 billion in 2014. The effects of the global crisis are carefully considered when estimating market. Market application is filed in the markets for the treatment of autoimmune diseases and systemic autoimmune diseases localized. The market is dominated applications Rheumatoid arthritis mainly in the segment of the systemic disease, while MS is the market segment of the main applications of localized disease. These two conditions represent 75% of the total market demands. Other key issues discussed in terms the market applications are psoriasis, lupus, diabetes type I, inflammatory bowel disease and thyroid disorders, which together account for 15% -20% of global market demands. Falling market in terms of drugs, diagnostic equipment, therapeutic and monitoring. Drugs are the largest segment of the market products, with the main drugs as NSAIDs, DMARDs, biologic DMARDs, Avonex, Rebif, Copaxone, Betaseron, and 5-ASA. The services market is consultation and diagnosis, treatment and monitoring, drug development. The high and increasing prevalence of autoimmune diseases is driving the market for drugs, and treatment and market monitoring, coupled with the fact that almost all autoimmune diseases are chronic and have no cure. The drug market is estimated that an income of 24.38 billion dollars in 2009 and is growing with a CAGR of 12.5% from 2009 to 2014. Total market services and treatment monitoring and drug development is the largest contributor to take into account $ 9.31 billion in 2009 and growing at a CAGR of 14% from 2009-2014. For more information on the report, Please visit: title = "http://www.visionshopsters.com/product/1120/Autoimmune-Treatment-2009-2014-.html"> http://www.visionshopsters.com/product/1120/Autoimmune-Treatment-2009-2014 -. html or send us your request to: info@visionshopsters.com ----------------------------------- ---- -------
About the Author
VisionShopsters.com specializes in providing comprehensive collection of online market research reports, conference/events/seminars bookings, country reports, company profiles, latest books and magazines, customized research services offering informative solutions worldwide.
